158 related articles for article (PubMed ID: 23161304)
21. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
Vardas E; Sitas F; Seidel K; Casteling A; Sim J
Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus seroprevalence in the Netherlands.
Vriend HJ; Op de Coul EL; van de Laar TJ; Urbanus AT; van der Klis FR; Boot HJ
Eur J Public Health; 2012 Dec; 22(6):819-21. PubMed ID: 22461704
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
25. The epidemiology of hepatitis C in Turkey.
Thomas DL; Mahley RW; Badur S; Palaoglu E; Quinn TC
Infection; 1994; 22(6):411-4. PubMed ID: 7698839
[TBL] [Abstract][Full Text] [Related]
26. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon.
Ngatchu T; Stroffolini T; Rapicetta M; Chionne P; Lantum D; Chiaramonte M
J Trop Med Hyg; 1992 Feb; 95(1):57-61. PubMed ID: 1311043
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of anti-hepatitis C antibody among acute febrile illness cases in Idar Taluk, Gujarat, West India.
Nikitha S; Sabeena S; Robin S; Hiren D; Prasad V; Aswathyraj S; Devadiga S; Anup J; Arunkumar G
Indian J Med Microbiol; 2019; 37(2):225-229. PubMed ID: 31745023
[TBL] [Abstract][Full Text] [Related]
29. Studies on the prevalence of Hepatitis C virus infection in diabetic patients attending a tertiary health-care facility South-west Nigeria.
Ndako JA; Owolabi AO; Olisa JA; Akinwumi JA; Dojumo VT; Olatinsu O; Adebayo BA
BMC Infect Dis; 2020 Sep; 20(1):664. PubMed ID: 32907538
[TBL] [Abstract][Full Text] [Related]
30. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo.
Laurent C; Henzel D; Mulanga-Kabeya C; Maertens G; Larouzé B; Delaporte E
Int J Epidemiol; 2001 Aug; 30(4):872-7. PubMed ID: 11511619
[TBL] [Abstract][Full Text] [Related]
31. The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas.
Kalem F; Yüksekkaya Ş; Başaranoğlu M
Wien Klin Wochenschr; 2016 Oct; 128(19-20):695-699. PubMed ID: 25869760
[TBL] [Abstract][Full Text] [Related]
32. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia.
Loviselli A; Oppo A; Velluzzi F; Atzeni F; Mastinu GL; Farci P; Orgiana G; Balestrieri A; Cocco PL; Mariotti S
J Endocrinol Invest; 1999 Oct; 22(9):660-5. PubMed ID: 10595828
[TBL] [Abstract][Full Text] [Related]
33. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
35. CROSS SECTIONAL STUDY OF PREVALENCE AND RISK FACTORS OF HEPATITIS B AND HEPATITIS C INFECTION IN A RURAL VILLAGE OF INDIA.
Bhate P; Saraf N; Parikh P; Ingle M; Phadke A; Sawant P
Arq Gastroenterol; 2015 Dec; 52(4):321-4. PubMed ID: 26840475
[TBL] [Abstract][Full Text] [Related]
36. [Seroepidemiological investigation of hepatitis C virus in Zhejiang Province: a hospital-based study].
Chen P; Zheng Y; Gao HR; Zou PF; Zhou ZB; Ge YH; Li SB; Shen YQ; Li LJ
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):940-944. PubMed ID: 30669788
[No Abstract] [Full Text] [Related]
37. Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors.
Barakat SH; El-Bashir N
J Viral Hepat; 2011 Nov; 18(11):779-84. PubMed ID: 21992795
[TBL] [Abstract][Full Text] [Related]
38. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey.
Davaalkham D; Ojima T; Nymadawa P; Uehara R; Watanabe M; Oki I; Nakamura Y
J Med Virol; 2006 Apr; 78(4):466-72. PubMed ID: 16482536
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey.
Gulcan A; Gulcan E; Toker A; Bulut I; Akcan Y
J Investig Med; 2008 Aug; 56(6):858-63. PubMed ID: 18667903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
